Cargando…
Enhancing the Delivery of Erythropoietin and Its Variants into the Ischemic Brain
The hematopoietic growth factor erythropoietin (EPO) and its neuroprotective, but not hematopoietic, variants asialoEPO, carbamylated EPO (CEPO), and low sialic acid EPO (Neuro-EPO) are attractive candidates for stroke treatment. Due to their large molecular weight, these proteins enter the brain on...
Autor principal: | Hermann, Dirk M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823085/ https://www.ncbi.nlm.nih.gov/pubmed/19768353 http://dx.doi.org/10.1100/tsw.2009.104 |
Ejemplares similares
-
Nonhematopoietic Variants of Erythropoietin in Ischemic Stroke: Need for Step-Wise Proof-of-Concept Studies
por: Hermann, Dirk M.
Publicado: (2010) -
Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017) -
Contribution of polymorphonuclear neutrophils in the blood periphery to ischemic brain injury
por: Hermann, Dirk M., et al.
Publicado: (2019) -
Erythrocytes and Erythropoietin
por: Föller, Michael, et al.
Publicado: (2011) -
The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017)